Results 21 to 30 of about 11,149 (190)

Histopathologic spectrum of vulvar lesions in South India with an emphasis on morphological classification of vulvar squamous cell carcinoma: a retrospective study of 8 years

open access: yesJournal of the Egyptian Women’s Dermatologic Society, 2019
Background Vulvar diseases comprise inflammatory and neoplastic conditions. Comprehensive data in Indian population is lacking. Vulva is also prone to HPV related lesions and the prevalence of HPV related vulvar squamous cell carcinoma (SCC) in the study
Gayatri Ravikumar   +2 more
doaj   +1 more source

Vulvar basal cell carcinoma, a rare location [PDF]

open access: yesJournal of Clinical and Investigative Surgery, 2018
Basal Cell Carcinoma is the most common human malignant neoplasm. Vulvar basal cell carcinoma is rare, accounting for less than 5% of all vulvar neoplasms.
Cornelia Nitipir   +5 more
doaj   +1 more source

Spontaneous Massive Vulvar Edema in Pregnancy: A Case Report

open access: yesCase Reports in Obstetrics and Gynecology, 2018
Spontaneous massive vulvar edema in pregnancy is unusual and a cause for concern. This condition should be taken seriously since it might be caused by some conditions such as preeclampsia, diabetes, vulvovaginitis, severe anemia, and neoplasms. We report
Olivier Mulisya   +4 more
doaj   +1 more source

Apocrine adenocarcinoma of the vulva

open access: yesRare Tumors, 2013
Cutaneous vulvar carcinomas are predominantly of squamous cell carcinoma type. Primary vulvar adenocarcinomas are rare with a poorly understood histogenesis.
Babita Kajal   +3 more
doaj   +1 more source

Sebaceous Carcinoma of the Vulva: An Unexpected Diagnosis and Literature Review

open access: yesActa Médica Portuguesa, 2022
Sebaceous carcinoma of the vulva is a rare malignancy of the sebaceous glands, with potentially aggressive behaviour, that is usually found in the peri-ocular area.
Ana Carolina Rocha   +3 more
doaj   +1 more source

Report of Incidental Vulvar Malignant Melanoma Upon Dermatologic Evaluation for Vaginal Cyst

open access: yesInternational Journal of Medical Students, 2023
BACKGROUND: Vulvar malignant melanoma is a rare, often aggressive and recurring disease with a poorly understood prognosis. Here, we describe a patient with a longstanding vaginal cyst who was diagnosed with vulvar malignant melanoma upon a dermatologic
Vrusha K. Shah   +4 more
doaj   +1 more source

Background and precancerous processes in the vulva and vagina: etiology, pathogenesis, diagnosis and treatment

open access: yesАкушерство, гинекология и репродукция, 2019
Leukoplakia, kraurosis and pointed condylomas (papillomas) of the vulva represent the group of background benign vulvar diseases. Vulvar and vaginal intraepithelial neoplasms are classified as premalignant conditions.
A. G. Solopova   +5 more
doaj   +1 more source

Biomimetic Scaffold‐Based 3D Models for Decoding Cancer Biology and Advancing Therapy

open access: yesAdvanced Science, EarlyView.
A timeline of the research history of 3D biomimetic scaffold materials and platforms. With advances in biomimetic materials and 3D scaffold technologies, their functional scope has expanded from mimicking basic physical and biochemical properties to increasingly replicating complex pathophysiological processes.
Haitao Zhao   +10 more
wiley   +1 more source

Progressing Vulvar Melanoma Caused by Instability in cKIT Juxtamembrane Domain: A Case Report and Review of Literature

open access: yesCurrent Oncology, 2022
In order to identify the molecular pathways governing melanoma and track its progression, the next-generation sequencing (NGS) approach and targeted sequencing of cancer genes were employed.
Monika Englert-Golon   +9 more
doaj   +1 more source

Maternal and Neonatal Complications Associated with Breast Cancer Systemic Treatments—A VigiBase Disproportionality Analysis Study

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Pregnancy‐associated breast cancer (PrBC) presents therapeutic challenges. Understanding maternal–fetal safety of systemic anticancer therapies is critical. We performed a case/non‐case disproportionality analysis using the WHO global pharmacovigilance database up to January 2024, to evaluate maternal–fetal outcomes associated with breast cancer (BC ...
Rayan Kabirian   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy